Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 CAD | 0.00% | -3.18% | +15.52% |
17/05 | XORTX Therapeutics Reprices Warrants Connected With U.S. IPO | MT |
17/05 | XORTX Therapeutics Brief: Says Repriced Balance of Warrants Issued in Connection with October 2021 US IPO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.52% | 71.37L | |
+9.49% | 11TCr | |
+11.78% | 11TCr | |
-2.79% | 2.2TCr | |
-14.23% | 2.19TCr | |
-5.29% | 1.92TCr | |
-4.01% | 1.81TCr | |
-38.29% | 1.77TCr | |
+7.16% | 1.43TCr | |
+35.90% | 1.24TCr |
- Stock Market
- Equities
- XRTX Stock
- News XORTX Therapeutics Inc.
- XORTX Submits Orphan Drug Designation Application to European Medicines Agency to Treat Progressive Kidney Disease